Discovery of a Lead Brain‐Penetrating Gonadotropin‐Releasing Hormone Receptor Antagonist with Saturable Binding in Brain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Discovery of a Lead Brain‐Penetrating Gonadotropin‐Releasing Hormone Receptor Antagonist with Saturable Binding in Brain ; volume:15 ; number:17 ; year:2020 ; pages:1624-1628 ; extent:5
ChemMedChem ; 15, Heft 17 (2020), 1624-1628 (gesamt 5)
- Urheber
-
Bekker, Roberto B. W.
Fjellaksel, Richard
Hjornevik, Trine
Nuruddin, Syed
Rafique, Waqas
Hansen, Jørn H.
Sundset, Rune
Haraldsen, Ira H.
Riss, Patrick J.
- DOI
-
10.1002/cmdc.202000256
- URN
-
urn:nbn:de:101:1-2022062807255776167675
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bekker, Roberto B. W.
- Fjellaksel, Richard
- Hjornevik, Trine
- Nuruddin, Syed
- Rafique, Waqas
- Hansen, Jørn H.
- Sundset, Rune
- Haraldsen, Ira H.
- Riss, Patrick J.
Ähnliche Objekte (12)
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor
Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
Untersuchungen zur Standardisierung von Gonadotropin-Releasing-Aktivität
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Östrogeneinfluss auf den Gonadotropin-Releasing-Hormonstoffwechsel des Menschen
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor
Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
Untersuchungen zur Standardisierung von Gonadotropin-Releasing-Aktivität
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Östrogeneinfluss auf den Gonadotropin-Releasing-Hormonstoffwechsel des Menschen
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor
Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
Untersuchungen zur Standardisierung von Gonadotropin-Releasing-Aktivität
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Östrogeneinfluss auf den Gonadotropin-Releasing-Hormonstoffwechsel des Menschen